SC 13G
PUMA BIOTECHNOLOGY, INC.
- Company
- PUMA BIOTECHNOLOGY, INC.
- Filed
- February 16, 2021
- Accession Number
- 0001193125-21-045077
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →